Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: Influence of strain and contribution of dopamine D2, but not D3 and D4 receptors

Behavioural Pharmacology

Volumn 20, Issue 4, 2009, Pages 303-311

  Depoortère, Ronan ^a   Bardin, Laurent ^a   Rodrigues, Michael ^a   Abrial, Erika ^a   Aliaga, Monique ^a   Newman Tancredi, Adrian ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Apomorphine; Dopamine D2 receptor; Penile erection; Rats; Yawning

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; ABT 724; APOMORPHINE; CP 226 269; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; L 741626; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; QUINELORANE; RBI 257; RO 10 5824; S 33084; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; LONG EVANS RAT; MALE; NONHUMAN; PENIS ERECTION; RAT; SPRAGUE DAWLEY RAT; WISTAR RAT; YAWNING;

ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; PENILE ERECTION; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; SPECIES SPECIFICITY; YAWNING;

EID: 68449090716     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32832ec5aa     Document Type: Article

References (39)

1. Andersen ML, Perry JC, Bignotto M, Perez-Mendes P, Cinini SM, Mello LEJufik S (2007). Influence of chronic cocaine treatment and sleep deprivation onsexual behavior and neurogenesis of the male rat. ProgNeuropsychophar-macol Biol Psychiatry 31:1224-1229.
2. 3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehydeoxidase. Xenobiotica 31:677-686.
3. 1Aagonist properties. Neuropsychopharmacol 31:1869-1879.
4. 1A activity: comparison withtypical and atypical conventional antipsychotics. BehavPharmacol 18:103-118.
5. Benassi-Benelli A, Ferrari F, Quarantotti BP (1979). Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats. Arch Int Pharmacodyn Ther 242:241-247.
6. Bernabe J, Rampin O, Sachs BD, Giuliano F (1999). Intracavernous pressure during erection in rats: anintegrative approach based on telemetric recording. Am JPhysiol 276:441-449.
7. 4 receptors by ABT-724 induces penile erection inrats. Proc Natl Acad Sci USA 101:6758-6763.
8. CarsonCC (2008). Commentary on apomorphine versus sildenafil for erectiledysfunction. J Urol 179:S95-96.
9. 3receptor-mediated behavior. J Pharmacol Exp Ther 314:310-319.
10. 2agonists and antagonists. Psychopharmacology 193:159-170.
11. 4, receptor in the rat. SanDiego: Society for Neurosciences.710.11.
12. 3 receptor in rats and mice. J Pharmacol Exp Ther 399:210-217.
13. Cowart M, Latshaw SP, Bhatia P, Daanen JF, Rohde J, Nelson SL, et al. (2004). Discovery of2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1 H-benzimidazole (ABT-724), adopaminergic agent with a novel mode of action for the potentialtreatment of erectile dysfunction. J Med Chem 47:3853-3864.
14. 3 receptors: use of the knock-out mice approach. In: DiChiara G, editor. Dopamine in the CNS II. Springer: Heildeberg; pp. 239-264.
15. 3 receptor antagonist. Bioorg Med Chem Lett 9:2059-2064.
16. Gower AJ, Berendsen HG, Princen MM, BroekkampCL (1984). The yawningpenile erection syndrome as a model forputative dopamine autoreceptor activity. Eur J Pharmacol 103:81-89.
17. Gower AJ, Berendsen HH, Broekkamp CL (1986). Antagonism of drug-induced yawning and penile erections in rats. Eur J Pharmacol 122:239-244.
18. 3 receptor. J Med Chem 48:839-848.
19. Hsieh GC, Hollingsworth PR, Martino B, Chang R, Terranova MA, O'Neill AB, et al. (2004). Central mechanismsregulating penile erection in conscious rats: the dopaminergicsystems related to the proerectile effect of apomorphine. JPharmacol Exp Ther 308:330-338.
20. 4 receptor-selective ligand. Eur JPharmacol 331:333-336.
21. 4 receptor. J MedChem 39:1941-1942.
22. Lal S, Ackman D, Thavundayil JX, Kiely ME, Etienne P (1984). Effect of apomorphine, a dopaminereceptor agonist, on penile tumescence in normal subjects. ProgNeuropsychopharmacol Biol Psychiatry 8:695-699.
23. Lal S, Laryea E, Thavundayil JX, Nair NP, Negrete J, Ackman D, et al. (1987). Apomorphine-induced penile tumescence in impotent patientspreliminary findings. Prog Neuropsychopharmacol BiolPsychiatry 11:235-242.
24. Lal S, Tesfaye Y, Thavundayil JX, Skorzewska A, Schwartz G (2000). Effect of time-of-day on theyawning response to apomorphine in normal subjects. Neuropsychobiol 41:178-180.
25. 4 receptoragonists, induce penile erection in male rats: site and mechanism ofaction in the brain. Eur J Neurosci 24:2021-2030.
26. Millan MJ, Dekeyne A, Rivet JM, Dubuffet T, Lavielle G, Brocco M (2000). S33084, a novel, potent, selective, and competitiveantagonist at dopamine D(3)-receptors: II. Functional and behavioralprofile compared with GR218,231 and L741,626. J Pharmacol ExpTher 293:1063-1073.
27. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A (2002). Differential actions of antiparkinson agents at multiple classes of monoaminergicreceptor. I. A multivariate analysis of the binding profiles of 14drugs at 21 native and cloned human receptor subtypes. J PharmacolExp Ther 303:791-804.
28. 2 receptorsenhances frontocortical cholinergic transmission and social memory inrats: a parallel neurochemical and behavioural analysis. JNeurochem 100:1047-1061.
29. Mogilnicka E, Klimek V (1977). Drugs affecting dopamine neurons and yawning behavior. PharmacolBiochem Behav 7:303-305.
30. 4 receptor agonist in rats. Pharmacol BiochemBehav 82:140-147.
31. 3 receptor. Bioorg Med Chem Lett 6:403-408.
32. 4, receptor agonists are emetogenic in ferrets. Pharmacol Biochem Behav 81:211-219.
33. 4 agonist for the treatment of erectile dysfunction. JMed Chem 49:7450-7465.
34. Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, et al. (2000). Pharmacological actions of a novel, high-affinity, and selectivehuman dopamine D(3) receptor antagonist, SB-277011-A. J PharmacolExp Ther 294:1154-1165.
35. Segraves RT, Bari M, Segraves K, Spirnak P (1991). Effect of apomorphine on penile tumescence inmen with psychogenic impotence. J Urol 145:1174-1175.
36. 2 post-synaptic receptor agonist. Eur J Pharmacol 323:27-36.
37. Stemp G, Ashmeade T, Branch CL, Hadley MS, Hunter AJ, Johnson CN, et al. (2000). Design and synthesis oftrans-N-[4-[2-(6-cyano-1,2,3,4- tetrahydroi-soquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide(SB-277011): a potent and selective dopamine D(3) receptor antagonistwith high oral bioavailability and CNS penetration in the rat. JMed Chem 43:1878-1885.
38. Varrin S, Heaton JP (1992). Age-related changes in apomorphine-induced erections. NeurobiolAging 13:175-177.
39. 2 receptor occupancypredicts catalepsy and the suppression of conditioned avoidanceresponse behavior in rats. Psychopharmacology 150:422-429.